INTRACOASTAL CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for PharmaCyte Biotech, Inc. Common Stock, $0.0001 par value per share

Filing Manager: INTRACOASTAL CAPITAL, LLC
Reporting Manager: Mitchell P. Kopin
Security: PharmaCyte Biotech, Inc. Common Stock, $0.0001 par value per share
Shares outstanding: 7,155,596 shares
Disclosed Ownership: 714,844 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 15 Jan 2025, 16:03:44 UTC
Date of event: 31 Dec 2024
Next filing: 07 Nov 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title
Mitchell P. Kopin	10%	714,844	0	714,844	/s/ Mitchell P. Kopin	Mitchell P. Kopin
Daniel B. Asher	10%	705,663	82,727	622,936	/s/ Daniel B. Asher	Daniel B. Asher
Intracoastal Capital LLC	10%	714,844	0	714,844	/s/ Mitchell P. Kopin	Mitchell P. Kopin, Manager